Literature DB >> 29147923

Anti-aminoacyl-tRNA synthetase-related myositis and dermatomyositis: clues for differential diagnosis on muscle biopsy.

Bruna Cerbelli1, Annalinda Pisano1, Serena Colafrancesco2, Maria Gemma Pignataro1, Marco Biffoni3, Silvia Berni1, Antonia De Luca1, Valeria Riccieri2, Roberta Priori2, Guido Valesini2, Giulia d'Amati1, Carla Giordano4.   

Abstract

Anti-synthetase syndrome is an autoimmune disease characterized by autoantibodies toward amino acyl-tRNA synthetases (ARS), anti-Jo 1 being the most commonly detected. Muscle damage develops in up to 90% of ARS-positive patients, characterized by a necrotizing myositis restricted to the perifascicular region. This topographic distribution of muscle damage may lead to a misdiagnosis of dermatomyositis (DM) at muscle biopsy. We compared morphological, immunohistochemical, and histoenzymatic features of muscle from ARS-positive patients (n = 11) with those of DM (n = 7) providing clues for their differential diagnosis. In addition, we evaluated markers of mitochondrial damage to provide a further distinction between these two entities. Necrosis occurred in the majority of ARS patients, mainly located in the perifascicular region. It was often limited to small foci of fibers, always associated with myocyte regeneration. This last often overwhelmed necrosis, representing occasionally the main finding. In DM, necrosis/regeneration was scarce while the peculiar feature was a diffuse atrophy of perifascicular fibers. These last showed decreased cytochrome c oxidase (COX) stain and mitochondrial DNA depletion, consistent with mitochondrial dysfunction. In contrast to DM, ARS displayed scattered COX-deficient fibers, not restricted to the perifascicular region. This feature occurred in up to 91% of patients, being prominent only in two.

Entities:  

Keywords:  Anti-synthetase syndrome; Dermatomyositis; Muscle biopsy; Myositis; mtDNA damage

Mesh:

Substances:

Year:  2017        PMID: 29147923     DOI: 10.1007/s00428-017-2269-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  35 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 2.  Acquired immune and inflammatory myopathies: pathologic classification.

Authors:  Alan Pestronk
Journal:  Curr Opin Rheumatol       Date:  2011-11       Impact factor: 5.006

3.  119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands.

Authors:  Jessica E Hoogendijk; Anthony A Amato; Bryan R Lecky; Ernest H Choy; Ingrid E Lundberg; Michael R Rose; Jiri Vencovsky; Marianne de Visser; Richard A Hughes
Journal:  Neuromuscul Disord       Date:  2004-05       Impact factor: 4.296

Review 4.  Inflammatory muscle diseases.

Authors:  Marinos C Dalakas
Journal:  N Engl J Med       Date:  2015-04-30       Impact factor: 91.245

5.  Perifascicular necrosis in anti-synthetase syndrome beyond anti-Jo-1.

Authors:  Akinori Uruha; Shigeaki Suzuki; Norihiro Suzuki; Ichizo Nishino
Journal:  Brain       Date:  2016-06-05       Impact factor: 13.501

6.  Dermatomyositis (systemic angiopathy) of childhood.

Authors:  B Q Banker; M Victor
Journal:  Medicine (Baltimore)       Date:  1966-07       Impact factor: 1.889

7.  Cytochrome c oxidase-intermediate fibres: importance in understanding the pathogenesis and treatment of mitochondrial myopathy.

Authors:  Julie L Murphy; Thiloka E Ratnaike; Ersong Shang; Gavin Falkous; Emma L Blakely; Charlotte L Alston; Tanja Taivassalo; Ronald G Haller; Robert W Taylor; Doug M Turnbull
Journal:  Neuromuscul Disord       Date:  2012-05-28       Impact factor: 4.296

Review 8.  Overlap connective tissue disease syndromes.

Authors:  Luca Iaccarino; Mariele Gatto; Silvano Bettio; Francesco Caso; Mariaelisa Rampudda; Margherita Zen; Anna Ghirardello; Leonardo Punzi; Andrea Doria
Journal:  Autoimmun Rev       Date:  2012-06-26       Impact factor: 9.754

9.  Mitochondrial and inflammatory changes in sporadic inclusion body myositis.

Authors:  Karolina A Rygiel; James Miller; John P Grady; Mariana C Rocha; Robert W Taylor; Doug M Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2015-04       Impact factor: 8.090

10.  Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.

Authors:  Yves Troyanov; Ira N Targoff; Marie-Pier Payette; Jean-Pierre Raynauld; Suzanne Chartier; Jean-Richard Goulet; Josiane Bourré-Tessier; Eric Rich; Tamara Grodzicky; Marvin J Fritzler; France Joyal; Martial Koenig; Jean-Luc Senécal
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

View more
  1 in total

Review 1.  Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond.

Authors:  Angeles S Galindo-Feria; Antonella Notarnicola; Ingrid E Lundberg; Begum Horuluoglu
Journal:  Front Immunol       Date:  2022-05-13       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.